Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro

• DOI: 10.3892/or.2016.5114
• Publication Date: 2016-09-20T11:24:42Z
• Authors: Silvio Holzner; Daniel Senfter; Serena Stadler; Anna Staribacher; Chi Huu Nguyen; Anna Gaggl; Silvana Geleff; Nicole Huttary; Sigurd Krieger; Walter Jäger; Helmut Dolznig; Robert M. Mader; Georg Krupitza
• Keywords: EXPRESSION; 0301 basic medicine; 301209 Pharmazie; INVASION; colorectal cancer; exosomes; Intercellular epigenetics; Exosomes; MicroRNA200; 03 medical and health sciences; 301209 Pharmacy; SDG 3 - Good Health and Well-being; Cell Movement; Isothiocyanates; Cell Line, Tumor; Spheroids, Cellular; intercellular epigenetics; XENOGRAFTS; Humans; Lymphatic Vessels; drug resistance; Blood endothelial barrier breaching; COLON-CANCER; NF-kappa B; Endothelial Cells; SULFORAPHANE; blood endothelial barrier breaching; EPITHELIAL-MESENCHYMAL TRANSITION; Colorectal cancer; Coculture Techniques; FAMILY; 3. Good health; Gene Expression Regulation, Neoplastic; MICE; MicroRNAs; Pyrimidines; microRNA200; Drug resistance; SDG 3 – Gesundheit und Wohlergehen; Lymphatic Metastasis; Sulfoxides; METASTASIS; Benzamides; 5-FLUOROURACIL; Endothelium, Vascular; Colorectal Neoplasms

Since cancer cells, when grown as spheroids, display drug sensitivity and radiation resistance patterns such as seen in vivo we recently established a three‑dimensional (3D) in vitro model recapitulating colorectal cancer (CRC)-triggered lymphatic endothelial cell (LEC)‑barrier breaching to study mechanisms of intra‑/extravasation. CRC metastasizes not only through lymphatics but also through blood vessels and here we extend the 3D model to the interaction of blood endothelial cells (BECs) with naïve and 5‑fluorouracil (5‑FU)‑resistant CRC CCL227 cells. The 3D model enabled quantifying effects of tumour‑derived microRNA200 (miR200) miR200a, miR200b, miR200c, miR141 and miR429 regarding the induction of so-called 'circular chemorepellent‑induced defects' (CCIDs) within the BEC‑barrier, which resemble gates for tumour transmigration. For this, miR200 precursors were individually transfected and furthermore, the modulation of ZEB family expression was analysed by western blotting. miR200c, miR141 and miR429, which are contained in exosomes from naïve CCL227 cells, downregulated the expression of ZEB2, SNAI and TWIST in BECs. The exosomes of 5‑FU‑resistant CCL227‑RH cells, which are devoid of miR200, accelerated CCID formation in BEC monolayers as compared to exosomes from naïve CCL227 cells. This confirmed the reported role of ZEB2 and SNAI in CRC metastasis and highlighted the active contribution of the stroma in the metastatic process. CCL227 spheroids affected the integrity of BEC and LEC barriers alike, which was in agreement with the observation that CRC metastasizes via blood stream (into the liver) as well as via lymphatics (into lymph nodes and lungs). This further validated the CRC/LEC and CRC/BEC in vitro model to study mechanisms of CRC spreading through vascular systems. Treatment of CCL227‑RH cells with the HDAC inhibitors mocetinostat and sulforaphane reduced CCID formation to the level triggered by naïve CCL227 spheroids, however, without significantly influencing miR200 expression in CCL227-RH cells.